HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer.
about
miR-222/VGLL4/YAP-TEAD1 regulatory loop promotes proliferation and invasion of gastric cancer cells.Gastric cancer - clinical and epidemiological aspects.Cancer Transcriptome Dataset Analysis: Comparing Methods of Pathway and Gene Regulatory Network-Based Cluster Identification.HNF4A expression as a potential diagnostic tool to discriminate primary gastric cancer from breast cancer metastasis in a Brazilian cohort.Improving gastric cancer preclinical studies using diverse in vitro and in vivo model systems.Differential Effects of Hepatocyte Nuclear Factor 4α Isoforms on Tumor Growth and T-Cell Factor 4/AP-1 Interactions in Human Colorectal Cancer Cells.The effects of a novel aliphatic-chain hydroxamate derivative WMJ-S-001 in HCT116 colorectal cancer cell death.Mutual amplification of HNF4α and IL-1R1 composes an inflammatory circuit in Helicobacter pylori associated gastric carcinogenesisOpposing roles of nuclear receptor HNF4α isoforms in colitis and colitis-associated colon cancer.Decreased LIPF expression is correlated with DGKA and predicts poor outcome of gastric cancerMetformin reduces gastric cancer risk in patients with type 2 diabetes mellitus.Integrated epigenomic analyses of enhancer as well as promoter regions in gastric cancer.Clinical Relevance and Molecular Phenotypes in Gastric Cancer, of TP53 Mutations and Gene Expressions, in Combination With Other Gene Mutations.Systematic approach identifies RHOA as a potential biomarker therapeutic target for Asian gastric cancer.DHQZ-17, A POTENT INHIBITOR OF THE TRANSCRIPTION FACTOR HNF4A, SUPPRESSES TUMORIGENICITY OF HEAD & NECK SQUAMOUS CELL CARCINOMA IN VIVO.Databases and tools for constructing signal transduction networks in cancer.CANcer-specific Evaluation System (CANES): a high-accuracy platform, for preclinical single/multi-biomarker discovery.Role of AMP-activated protein kinase α1 in 17α-ethinylestradiol-induced cholestasis in rats.Identifying heterogeneous subtypes of gastric cancer and subtype‑specific subpaths of microRNA‑target pathways.Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT.Gastric cancer biomarkers; A systems biology approach.Regulatory feedback loops bridge the human gene regulatory network and regulate carcinogenesis.Berberine Attenuated Proliferation, Invasion and Migration by Targeting the AMPK/HNF4α/WNT5A Pathway in Gastric CarcinomaTranscriptome sequencing identifies key pathways and genes involved in gastric adenocarcinoma
P2860
Q29347531-780D7F82-677A-484F-8C12-754ABAB8B621Q30248452-DE91D1D4-0DE8-4340-B9A8-7AE3504316F9Q33569864-43D75522-8065-4E7F-A6F6-3D4C06F06F51Q33767706-4199D5B3-4C1F-4542-A358-4A7FBD78F91AQ35949785-7F2AC449-F503-477E-B102-0B6FA2244683Q36070016-C6A70907-4F8C-4D48-8066-E3E32C911BDDQ36221605-E77A1CF4-BAAF-497C-8685-1241BA4EFD58Q36998254-8342896A-22C8-47AA-8BC4-9CCD1629F770Q37003742-AC555111-FFB8-4CFF-B912-560463516F14Q37255517-9E57665B-F60E-4A60-8C56-6FC30C5A00CCQ37274957-0D4248B7-7659-43A7-B774-4DBFC13C65B8Q37295443-20DB0A32-514B-443F-A75B-66B2D67E8731Q37314818-09D84405-135A-44DA-8742-F748CB31982DQ37697178-C2805FEA-A4EA-4C31-BEDC-6A4AD9831194Q38646088-DCAB90D9-BE57-4D74-8BE1-7116FF706708Q38922006-D5B25614-A17A-4AD2-96CA-980159B44CB9Q42378383-81DB3646-D2F5-4C5A-B0DA-C9DA4AB87B21Q42697966-CB233656-F82E-42E6-85CC-ECDEF29AB05BQ47235540-D94AAD85-34B0-4E46-8FAF-E2AA55E97C36Q50009971-395B0ABA-6CCE-4EBB-A87A-E0209A5B80AFQ52725533-580392AB-6E09-4F3F-94D2-B0814E3F82FCQ53180121-7955C05B-C8EA-4020-B3E8-2A5999D74964Q58587589-2A6589C5-257D-42B2-98F5-67CC011CF952Q58792261-9629D4BC-EB53-473A-A803-C714A15A479B
P2860
HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
HNF4α is a therapeutic target ...... in early-stage gastric cancer.
@ast
HNF4α is a therapeutic target ...... in early-stage gastric cancer.
@en
type
label
HNF4α is a therapeutic target ...... in early-stage gastric cancer.
@ast
HNF4α is a therapeutic target ...... in early-stage gastric cancer.
@en
prefLabel
HNF4α is a therapeutic target ...... in early-stage gastric cancer.
@ast
HNF4α is a therapeutic target ...... in early-stage gastric cancer.
@en
P2093
P2860
P1433
P1476
HNF4α is a therapeutic target ...... in early-stage gastric cancer.
@en
P2093
Chang-Gong Liu
Dongfeng Tan
Dongwan Hong
Hae Rim Jung
Hae Ryung Chang
Hee Seo Park
Hye Hyun Seo
P2860
P356
10.1136/GUTJNL-2014-307918
P407
P50
P577
2014-11-19T00:00:00Z